AHA Enduring Webinar: HIV and Cardiovascular Disease: Beyond Coronary Heart Disease
The program reviews epidemiologic patterns in HIV and the relevance of these for understanding the scope of CVD among HIV-infected individuals. Important concepts related to atherosclerotic and non-atherosclerotic cardiovascular diseases in people living with HIV, focusing on heart failure, arrhythmias and sudden cardiac death will be discussed; including new developments and existing barriers regarding CVD treatment for HIV-infected individuals.
View Activity Information

AHA Enduring Webinar: HIV and Cardiovascular Disease: Beyond Coronary Heart Disease

Participation and Successful Completion
Successful completion of this CE activity includes the following: 

  1. Register and view the course online.
  2. View the content in its entirety.
  3. Complete a post-test with a minimum score of 80%.
  4. Complete a survey of your learning experience.
  5. Claim your CME/CE Certificate.


Hardware/Software Requirements

Internet Explorer 7 or greater, Firefox (Latest Version), Google Chrome, Windows 7 or above, Safari (Latest Version), Adobe Acrobat Reader, Internet Explorer is not supported on the Macintosh, Mac OS 10.4
 

Target Audience
Physicians –
Cardiology, Family Practice, Infectious Disease, HIV specialist, Internal Medicine                       

Nurses, Nurse Practitioners –
Cardiology, Family Practice, Infectious Disease, HIV Specialist, Internal Medicine 

Other –
Physician Assistants in Cardiology, Family Practice, Infectious Diseases, HIV Specialist, Internal Medicine

Description
The program reviews epidemiologic patterns in HIV and the relevance of these for understanding the scope of CVD among HIV-infected individuals. Important concepts related to atherosclerotic and non-atherosclerotic cardiovascular diseases in people living with HIV, focusing on heart failure, arrhythmias and sudden cardiac death will be discussed; including new developments and existing barriers regarding CVD treatment for HIV-infected individuals.

Learning Objectives 
At the completion of this course, the learner will be able to: 

  1. Describe the general epidemiology of cardiovascular disease (CVD) related complications of human immunodeficiency (CVD) related complications.
  1. Describe risk factors and mechanisms of atherosclerotic CVD in HIV.
  1. Describe approaches to predict, prevent, and treat atherosclerotic CVD in HIV.
  1. Review the scope of non-atherosclerotic CVD in HIV as related mechanisms and treatment approaches.

 

Course Agenda

Time

Presentation Title

Faculty

Corresponding learning Objective (list by number)

60 minutes

General Epidemiology of HIV and CVD

HIV and Atherosclerotic CVD (ASCVD)

HIV and Non-Atherosclerotic CVD: Mechanisms and Therapies

Gerald S. Bloomfield, MD

Matthew S. Freiberg, MD, MSc

1-4


Faculty
Gerald S. Bloomfield, MD
Assistant Professor of Medicine
Assistant Research Professor of Global Health
Member in the Duke Clinical Research Institute
Duke University School of Medicine
Durham, NC 

Matthew S. Freiberg, MD, MSc
Associate Professor
Vanderbilt University Medical Center
Nashville, TN

Accreditation Statements:
ORIGINAL RELEASE DATE:  09/21/2017

TERMINATION DATE:  09/21/2020

LAST REVIEW DATE: July 2017

JOINT ACCREDITATION TERM: 09/21/2017 –09/21/2020

The American Heart Association is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

AMA Credit Designation Statement - Physicians
The American Heart Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.00 hours of Category 1 credit for completing this program.

AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. **AMA Credit must be claimed within 6 months of attendance. Credit will no longer be available to claim after the 6 months claiming period.

ANCC Credit Designation Statement - Nurses
The maximum number of hours awarded for this CE activity is 1.00 contact hours. **ANCC Credit must be claimed within 6 months of attendance. CME/CE will no longer be available to claim after the 6 months claiming period.

AAFP Credit Statement - Physicians
This Enduring Material activity, HIV and CVD: Beyond Coronary Heart Disease , has been reviewed and is acceptable for up to 1.00 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 09/21/2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures
All persons who develop and/or control educational content in CME/CE activities provided by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity.  In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations.  Such disclosures will be made in writing in course presentation materials.
 

Faculty Member

Employment

Research Grant

Consultant/
Advisory Board

Stock Shareholder (directly purchased)

Honoraria

Other

Speaker’s Bureau

David Weismiller

University of Nevada School of Medicine

None

None

None

None

None

Matthew Feinstein

Northwestern Medical Group

None

None

None

None

None

Priscilla Hsue

UCSF School of Medicine

Pfizer, Novartis

None

None

Gilean

None

Gerald Bloomfield

Duke University Medical Center

None

None

None

None

None

Matt Freiberg

Vanderbilt University, School of Medicine

None

None

None

None

None

Wendy Post

John Hopkins Cardiovascular Fellowship Research

None

None

None

None

None

Mark Harkwsky

University of Texas at Arlington

None

None

None

None

None

This table represents the relationships of this educational activity’s faculty members that may be perceived as actual or reasonable perceived conflicts of interest as reported on the Disclosure Questionnaire which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content.


Medium
This activity is a live or a virtual link activity depending on the location.

Contact Information
To contact the American Heart Association for any questions, please call our customer support center at 888-242-2453.
 

Policy on Privacy and Confidentiality:
Please see the privacy link at the bottom of the Lifelong Learning Center.
 

Copyright Information
Please see the link at the bottom of the Lifelong Learning Center.
 

Commercial Support
This activity is supported by independent medical educational grants from Gilead Sciences.


Type:  Internet Activity (Enduring Material)
FREE
Activity Price
333 Registered Users
Credits
1 Credits> Accreditation Council for Continuing Medical Education> AMA PRA Category 1 Credit

0 Credits> American Heart Association> AHA

1 Contact Hours> American Nurses Credentialing Center> ANCC

1 Credits> Accreditation Council for Continuing Medical Education> Attendance Credit

1 Credits> American Academy of Family Physicians (credit)> Prescribed